Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-β-D- arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling

Molecular Pharmacology

Volumn 54, Issue 5, 1998, Pages 844-856

  Jarvis, W David ^a   Fornari Jr , Frank A ^b   Tombes, Robert M ^a   Erukulla, Ravi K ^c   Bittman, Robert ^c   Schwartz, Gary K ^d   Dent, Paul ^a   Grant, Steven ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dominion   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SIGNAL TRANSDUCTION; STRESS;

EID: 0031785213     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.5.844     Document Type: Article

References (39)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR (1995) PD-098059 is a specific inhibitor of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, and Kolesnick RN (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414.
3. Brach MA, Herrmann F, and Kufe DW (1992a) Activation of the AP-1 transcription factor by 1-[β-D-arabinufuranosyl]cytosine in myeloid leukemia cells. Blood 79: 728-734.
4. Brach MA, Kharbanda SM, Herrmann F, and Kufe DW (1992b) Activation of the transcription factor κB in human myeloid leukemia cells treated with 1-[β-D-arabinofuranosyl]cytosine. Mol Pharmacol 41:60-63.
5. Coroneos E, Wang Y, Panushka JR, Templeton DJ, and Kester M (1996) Sphingolipid metabolites differentially regulate mitogen-regulated and stress-activated protein kinase cascades. Biochem J 316:13-17.
6. Dudley DT, Pang L, Decker SJ, Bridges AJ, and Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7690.
7. Grant S (1997) 1-[β-D-Arabinofuranosyl]cytosine: molecular and cellular pharmacology. Adv Cancer Res 72:197-233.
8. Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, and Jarvis WD (1996b) Effect of 1-[β-D-arabinofuranosyl]cytosine on apoptosis and differentiation in human monoblastic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM-67). Cell Growth Differ 7:603-613.
9. Grant S and Jarvis WD (1996) Modulation of drug-induced apoptosis by interruption of protein kinase C-dependent signaling pathways: evolution of a new chemotherapeutic strategy. Clin Can Res 2:1915-1920.
10. Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, and Jarvis WD (1994) Modulation of 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Oncol Res 6:87-99.
11. Grant S, Turner AJ, Freemerman AJ, Wang Z, Kramer LB, and Jarvis WD (1996a) Modulation of protein kinase C activity and calcium-sensitive isoform expression in myeloid leukemia cells by bryostatin 1: relationship to differentiation and 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis. Exp Cell Res 228:65-75.
12. Jarvis WD, Fornari FA, Browning JL, Gewirtz DA, Kolesnick RN, and Grant S (1994b) Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem 269:31658-31692.
13. Jarvis WD, Fornari FA, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Auer KL, Dent P, and Grant S (1997) Coordinate regulation of stress-activated protein kinase (SAPK) and mitogen-activated protein kinase (MAPK) cascades in the apoptotic actions of ceramide and sphingosine in human myeloid leukemia cells. Mol Pharmacol 52:935-947.
14. Jarvis WD, Fornari FA, Traylor RS, Martin HA, Kramer LB, Erukulla RK, Bittman R, and Grant S (1996) Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J Biol Chem 271:8275-8284.
15. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, and Grant S (1994a) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91:73-77.
16. Jarvis WD, Povirk LF, Turner AJ, Traylor RS, Gewirtz DA, Pettit GR, and Grant S (1994c) Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochem Pharmacol 47:838-852.
17. Kedderis CB, Bozigian HP, Kleiman JM, Hall LL, Palmer TE, Harrison SD, and Susick PL (1995) Toxicity of the protein kinase C inhibitor safingol administered alone or in combination with chemotherapeutic agents. Fundam Appl Toxicol 25:201-217.
18. Kharbanda SM, Datta R, and Kufe DW (1991) Regulation of c-jun expression in HL-60 leukemia cells by 1-[β-D-arabinofuranosyl]cytosme: potential involvement of a protein kinase C mechanism. Biochemistry 30:7747-7752.
19. Kharbanda SM, Emoto Y, Kiasaki H, Saleem A, and Kufe DW (1994) 1-[β-D-Arabinofuranosyl]cytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol diester-resistant myeloid leukemia cells. Mol Pharmacol 46:67-72.
20. Kharbanda SM, Sherman MC, and Kufe DW (1990) Transcriptional regulation of c-jun gene expression by 1-[β-D-arabinofuranosyl]cytosine in human myeloid leukemia cells. J Clin Invest 86:1517-1523.
21. Kucera GL and Capizzi RL (1992) 1-[β-D-Arabinofuranosyl]cytasine-diphosphate is formed by reversal of cholinephosphotransferase and not via cytidylyltransferase. Cancer Res 52:3886-3891.
22. Lee H-W, Smith L, Pettit GR, Vinitsky A, and Smith JD (1996) Ubiquitination of protein kinase C-α and degradation by the proteasome. J Biol Chem 271:20973-20978.
23. Lilly M, Brown C, Petit GR, and Kraft AS (1991) Bryostatin 1: a potential antileukemic agent for chronic myelomonocytic leukemia. Leukemia 5:283-287.
24. 3 positions. Biochim Biophys Acta 1256:25-30.
25. Mayo MW, Wang C-Y, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, and Baldwin AS (1997) Requirement of NFκB activation to suppress p53-dependent apoptosis induced by oncogenic ras. Science (Washington DC) 278:1812-1815.
26. Merrill AH, Nimkar S, Menaldino D, Hannun YA, Loomis C, Bell RM, Tyagi SR, Lambeth DJ, Stevens VL, Hunter R, and Liotta DC (1989) Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and the cellular efficacy of these compounds. Biochemistry 28:3138-3145.
27. Merrill AH, Wang E, Gilchrist DG, and Riley RT (1993) Fumonisin and other inhibitors of de novo sphingolipid biosynthesis. Adv Lipid Res 26:215-234.
28. Nomura H, Ase K, Sekiguchi K, Kikkawa U, Nishizuka Y, Nakano Y, and Satoh T (1986) Stereospecificity of diacylglycerol for stimulus-response coupling. Biochem Biophys Res Commun 140:1143-1151.
29. Go M, Sekiguchi K, Nomura H, Kikkawa U, and Nishizuka Y (1987) Further studies on the specificity of diacylglycerol for protein kinase C activation. Biochem Biophys Res Commun 144:598-605.
30. Saleem A, Datta R, Yuan Z-M, Kharbanda SM, and Kufe DW (1995) Involvement of stress-activated protein kinase in the cellular response to 1-[β-D-arabinofuranosyl]cytosine and other DNA-damaging agents. Cell Growth Differ 6:1651-1658.
31. Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F, Fuks Z, and Albino AP (1995) Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin-treated gastric carcinoma cells. J Natl Cancer Inst 87:1394-1399.
32. Strum JL, Small GW, Pauig SB, and Daniel LW (1994) 1-[β-D-Arabinofuranosyl]cytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 269:5493-15497.
33. Verheij M, Bose R, Lin X-H, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks ZY, and Kolesnick RN (1996) Requirement for ceramide-initiated SAPK-JNK signaling in stress-induced apoptosis. Nature (Lond) 380:75-79.
34. Wang LM and Kucera GL (1994) Deoxycytidine kinase in phosphorylated in vitro and in vivo by protein kinase C. Biochim Biophys Acta 1224:161-167.
35. Wang S, Vrana JA, Bartimole TM, Freemerman AJ, Jarvis WD, Kramer LB, Krystal G, Dent, P, and Grant S (1997) Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis in human myeloid leukemia cells over-expressing Bcl-2. Mol Pharmacol 52:1000-1009.
36. Westwick JK, Bielawska AE, Dbaibo GS, Hannun YA, and Brenner DA (1995) Ceramide activates the stress-activated protein kinases. J Biol Chem 270:22689-22692.
37. II activation by 1-[β-D-arabinofuranosyl]cytosine is antagonistic to stimulation of apoptosis by BCL2α. J Biol Chem 272:23481-23484.
38. Wiegmann K, Schutze S, Machleidt T, Witte D, and Kronke M (1994) Functional dichotomy of neutral and acidic sphingomyelinases in TNFα signaling. Cell 78: 1005-1015.
39. Xia Z, Dickens M, Raingeaud J, David RJ, and Greenberg ME (1995) Opposing effects of KRK, JNK, and RK kinases on apoptosis. Science (Washington DC) 270:1326-1331.